Naresuan University Hospital

Muang, Changwat Phitsanulok 65000

0 studies enrolling now · 2 studies all time

What they study most

Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer, First Line Non-Small Cell Lung Cancer

Studies at this site

• A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer — Running, not enrolling
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed